Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.6K citations

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Richard J. Pietras, Jane Arboleda, Reese Dm et al. · PubMed · 1995 · 608 citations

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.

S. Sjögren, Mats Inganäs, A. Lindgren et al. · Journal of Clinical Oncology · 1998 · 330 citations

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

Åke Borg, Bo Baldetorp, Mårten Fernö et al. · Cancer Letters · 1994 · 245 citations

Breast Oncology, Tamoxifen Resistance, Medicine +8

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

Bernard Têtu, Jacques Brisson · Cancer · 1994 · 205 citations · Full text